Tolerability and efficacy of anti-androgen manipulation versus taxotere and anti-androgen manipulation in patients with hormone-naive, high-risk/metastatic prostate cancer: A phase II, open-labeled, randomized study.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2011
At a glance
- Drugs Docetaxel (Primary) ; Goserelin
- Indications Prostate cancer
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms GENTAX
- 15 Mar 2011 New trial record
- 19 Feb 2011 Interim results presented at the 2011 Genitourinary Cancers Symposium.